|
Market Closed -
Nyse
01:30:02 18/04/2026 am IST
|
5-day change
|
1st Jan Change
|
|
228.12 USD
|
+1.51%
|
|
-0.33%
|
-5.29%
|
|
15/04 |
Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating
|
MT
| |
13/04 |
Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating
|
MT
| |
09/04 |
Resmed Insider Sold Shares Worth $1,125,486, According to a Recent SEC Filing
|
MT
| |
08/04 |
Citigroup Adjusts Price Target on ResMed to $340 From $345, Maintains Buy Rating
|
MT
| |
02/04 |
Resmed Insider Sold Shares Worth $450,000, According to a Recent SEC Filing
|
MT
| |
02/04 |
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
|
GL
| |
11/03 |
Resmed Insider Sold Shares Worth $1,252,902, According to a Recent SEC Filing
|
MT
| |
11/03 |
Baird Adjusts Price Target on ResMed to $272 From $281, Maintains Neutral Rating
|
MT
| |
06/03 |
Resmed Insider Sold Shares Worth $520,440, According to a Recent SEC Filing
|
MT
| |
04/03 |
Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains out of Reach
|
AQ
| |
04/03 |
ASX Biggest Gainers
|
MT
| |
03/03 |
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
|
GL
| |
27/02 |
SomnoMed Limited Announces Management Appointments
|
CI
| |
25/02 |
Shares of Resmed Fall 3% After Declaring Plan to Open New US Distribution Center
|
MT
| |
24/02 |
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
|
CI
| |
24/02 |
ResMed to Open New Distribution Center in Indiana
|
MT
| |
24/02 |
ResMed expands US operations with new distribution center in Indiana
|
RE
| |
24/02 |
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
|
GL
| |
12/02 | |
FA
| |
11/02 |
Resmed : Introduces Full Face Fabric Mask Designed for Comfort and Improved Sleep Health in the US
|
PU
| |
11/02 |
Resmed Insider Sold Shares Worth $1,366,436, According to a Recent SEC Filing
|
MT
| |
06/02 |
Resmed Insider Sold Shares Worth $502,620, According to a Recent SEC Filing
|
MT
| |
06/02 |
ResMed Chief Legal Officer Sells 50 Common Shares Of Firm
|
MT
| |
06/02 |
ResMed Director Sells 2,000 Shares
|
MT
| |
06/02 |
ASX Biggest Gainers
|
MT
|
No results for this search
Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|